---
document_datetime: 2025-12-29 14:34:03
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/sebivo.html
document_name: sebivo.html
version: success
processing_time: 0.1087544
conversion_datetime: 2025-12-30 03:16:49.963969
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Sebivo

[RSS](/en/individual-human-medicine.xml/65642)

##### Withdrawn

This medicine's authorisation has been withdrawn

telbivudine Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Sebivo](#more-information-on-sebivo-1038)
- [More information on Sebivo](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 5 November 2020, the marketing authorisation of Sebivo (telbivudine) ceased to be valid in the European Union (EU). Novartis Europharm Limited confirmed that it discontinued the marketing of the product due to commercial reasons.

The European Public Assessment Report (EPAR) for Sebivo is updated to indicate that the marketing authorisation is no longer valid.

Sebivo : EPAR - Summary for the public

English (EN) (630.47 KB - PDF)

**First published:** 27/02/2009

**Last updated:** 14/01/2021

[View](/en/documents/overview/sebivo-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-252)

български (BG) (804.14 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/bg/documents/overview/sebivo-epar-summary-public_bg.pdf)

español (ES) (691.41 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/es/documents/overview/sebivo-epar-summary-public_es.pdf)

čeština (CS) (771.3 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/cs/documents/overview/sebivo-epar-summary-public_cs.pdf)

dansk (DA) (631.84 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/da/documents/overview/sebivo-epar-summary-public_da.pdf)

Deutsch (DE) (693.47 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/de/documents/overview/sebivo-epar-summary-public_de.pdf)

eesti keel (ET) (630.76 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/et/documents/overview/sebivo-epar-summary-public_et.pdf)

ελληνικά (EL) (1.37 MB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/el/documents/overview/sebivo-epar-summary-public_el.pdf)

français (FR) (695.6 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/fr/documents/overview/sebivo-epar-summary-public_fr.pdf)

italiano (IT) (694.74 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/it/documents/overview/sebivo-epar-summary-public_it.pdf)

latviešu valoda (LV) (716.83 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/lv/documents/overview/sebivo-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (720.61 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/lt/documents/overview/sebivo-epar-summary-public_lt.pdf)

magyar (HU) (703.31 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/hu/documents/overview/sebivo-epar-summary-public_hu.pdf)

Malti (MT) (709.35 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/mt/documents/overview/sebivo-epar-summary-public_mt.pdf)

Nederlands (NL) (632.51 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/nl/documents/overview/sebivo-epar-summary-public_nl.pdf)

polski (PL) (770.06 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/pl/documents/overview/sebivo-epar-summary-public_pl.pdf)

português (PT) (631.13 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/pt/documents/overview/sebivo-epar-summary-public_pt.pdf)

română (RO) (661.02 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/ro/documents/overview/sebivo-epar-summary-public_ro.pdf)

slovenčina (SK) (707.64 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/sk/documents/overview/sebivo-epar-summary-public_sk.pdf)

slovenščina (SL) (702.81 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/sl/documents/overview/sebivo-epar-summary-public_sl.pdf)

Suomi (FI) (692.42 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/fi/documents/overview/sebivo-epar-summary-public_fi.pdf)

svenska (SV) (690.77 KB - PDF)

**First published:**

27/02/2009

**Last updated:**

14/01/2021

[View](/sv/documents/overview/sebivo-epar-summary-public_sv.pdf)

## Product information

Sebivo : EPAR - Product Information

English (EN) (1.4 MB - PDF)

**First published:** 12/10/2009

**Last updated:** 14/01/2021

[View](/en/documents/product-information/sebivo-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-538)

български (BG) (1.66 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/bg/documents/product-information/sebivo-epar-product-information_bg.pdf)

español (ES) (1.34 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/es/documents/product-information/sebivo-epar-product-information_es.pdf)

čeština (CS) (1.56 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/cs/documents/product-information/sebivo-epar-product-information_cs.pdf)

dansk (DA) (1.41 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/da/documents/product-information/sebivo-epar-product-information_da.pdf)

Deutsch (DE) (1.41 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/de/documents/product-information/sebivo-epar-product-information_de.pdf)

eesti keel (ET) (1.35 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/et/documents/product-information/sebivo-epar-product-information_et.pdf)

ελληνικά (EL) (1.67 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/el/documents/product-information/sebivo-epar-product-information_el.pdf)

français (FR) (1.46 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/fr/documents/product-information/sebivo-epar-product-information_fr.pdf)

hrvatski (HR) (1.46 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/hr/documents/product-information/sebivo-epar-product-information_hr.pdf)

íslenska (IS) (1.36 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/is/documents/product-information/sebivo-epar-product-information_is.pdf)

italiano (IT) (1.37 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/it/documents/product-information/sebivo-epar-product-information_it.pdf)

latviešu valoda (LV) (1.52 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/lv/documents/product-information/sebivo-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.44 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/lt/documents/product-information/sebivo-epar-product-information_lt.pdf)

magyar (HU) (1.56 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/hu/documents/product-information/sebivo-epar-product-information_hu.pdf)

Malti (MT) (1.67 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/mt/documents/product-information/sebivo-epar-product-information_mt.pdf)

Nederlands (NL) (1.37 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/nl/documents/product-information/sebivo-epar-product-information_nl.pdf)

norsk (NO) (1.38 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/no/documents/product-information/sebivo-epar-product-information_no.pdf)

polski (PL) (1.59 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/pl/documents/product-information/sebivo-epar-product-information_pl.pdf)

português (PT) (1.34 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/pt/documents/product-information/sebivo-epar-product-information_pt.pdf)

română (RO) (1.48 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/ro/documents/product-information/sebivo-epar-product-information_ro.pdf)

slovenčina (SK) (1.88 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/sk/documents/product-information/sebivo-epar-product-information_sk.pdf)

slovenščina (SL) (1.51 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/sl/documents/product-information/sebivo-epar-product-information_sl.pdf)

Suomi (FI) (1.4 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/fi/documents/product-information/sebivo-epar-product-information_fi.pdf)

svenska (SV) (1.39 MB - PDF)

**First published:**

12/10/2009

**Last updated:**

14/01/2021

[View](/sv/documents/product-information/sebivo-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** T/0050 12/04/2018

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Sebivo : EPAR - All Authorised presentations

English (EN) (581.67 KB - PDF)

**First published:** 21/10/2009

**Last updated:** 14/01/2021

[View](/en/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-437)

български (BG) (673.47 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/bg/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_bg.pdf)

español (ES) (582.72 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/es/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_es.pdf)

čeština (CS) (664.31 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/cs/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (582.18 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/da/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (582.64 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/de/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (582.61 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/et/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (669.46 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/el/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_el.pdf)

français (FR) (582.58 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/fr/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (610.09 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/hr/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (1.13 MB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/is/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_is.pdf)

italiano (IT) (581.87 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/it/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (668.65 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/lv/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (649.69 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/lt/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (665.68 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/hu/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (668.55 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/mt/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (581.77 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/nl/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (1.13 MB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/no/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_no.pdf)

polski (PL) (629.39 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/pl/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_pl.pdf)

português (PT) (582.37 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/pt/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_pt.pdf)

română (RO) (647.75 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/ro/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (665.81 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/sk/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (597.48 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/sl/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (582.04 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/fi/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (582.46 KB - PDF)

**First published:**

21/10/2009

**Last updated:**

14/01/2021

[View](/sv/documents/all-authorised-presentations/sebivo-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Sebivo Active substance telbivudine International non-proprietary name (INN) or common name telbivudine Therapeutic area (MeSH) Hepatitis B, Chronic Anatomical therapeutic chemical (ATC) code J05AF11

### Pharmacotherapeutic group

Nucleoside and nucleotide reverse transcriptase inhibitors

### Therapeutic indication

Sebivo is indicated for the treatment of chronic hepatitis B in adult patients with compensated liver disease and evidence of viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active inflammation and/or fibrosis.

Initiation of Sebivo treatment should only be considered when the use of an alternative antiviral agent with a higher genetic barrier to resistance is not available or appropriate.

## Authorisation details

EMA product number EMEA/H/C/000713 Marketing authorisation holder

Novartis Europharm Limited

Vista Building

Opinion adopted 22/02/2007 Marketing authorisation issued 24/04/2007 Revision 20

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Sebivo : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (597.43 KB - PDF)

**First published:** 12/10/2009

**Last updated:** 14/01/2021

[View](/en/documents/procedural-steps-after/sebivo-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Sebivo-H-C-PSUSA-2880-201608 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Reference Number: EMA/413022/2017

English (EN) (647.25 KB - PDF)

**First published:** 05/07/2017

**Last updated:** 14/01/2021

[View](/en/documents/scientific-conclusion/sebivo-h-c-psusa-2880-201608-epar-scientific-conclusions-and-grounds-variation-terms-marketing-authorisation_en.pdf)

Sebivo-H-C-00713-P46-0057 : EPAR - Assessment Report

Adopted

Reference Number: EMA/760212/2014

English (EN) (1.18 MB - PDF)

**First published:** 03/02/2015

**Last updated:** 14/01/2021

[View](/en/documents/variation-report/sebivo-h-c-00713-p46-0057-epar-assessment-report_en.pdf)

Sebivo-H-C-713-R-0023 : EPAR - Assessment Report - Renewal

Adopted

English (EN) (1.22 MB - PDF)

**First published:** 18/07/2012

**Last updated:** 14/01/2021

[View](/en/documents/variation-report/sebivo-h-c-713-r-0023-epar-assessment-report-renewal_en.pdf)

CHMP post-authorisation summary of positive opinion for Sebivo

Adopted

Reference Number: EMA/CHMP/123824/2012

English (EN) (680.52 KB - PDF)

**First published:** 17/02/2012

**Last updated:** 14/01/2021

[View](/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-sebivo_en.pdf)

## Initial marketing authorisation documents

Sebivo : EPAR - Scientific Discussion

English (EN) (885.34 KB - PDF)

**First published:** 08/05/2007

**Last updated:** 14/01/2021

[View](/en/documents/scientific-discussion/sebivo-epar-scientific-discussion_en.pdf)

Sebivo : EPAR - Procedural steps taken before authorisation

English (EN) (597.43 KB - PDF)

**First published:** 08/05/2007

**Last updated:** 14/01/2021

[View](/en/documents/procedural-steps/sebivo-epar-procedural-steps-taken-authorisation_en.pdf)

#### More information on Sebivo

Public statement on Sebivo: Withdrawal of the marketing authorisation in the European Union

Reference Number: EMA/594353/2020

English (EN) (152.83 KB - PDF)

**First published:** 14/01/2021

[View](/en/documents/public-statement/public-statement-sebivo-withdrawal-marketing-authorisation-european-union_en.pdf)

#### More information on Sebivo

- [EMEA-000065-PIP01-07-M05 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000065-pip01-07-m05)

**This page was last updated on** 14/01/2021

## Share this page

[Back to top](#main-content)